|
||
“The Cancer Divide: India’s Efforts to Aid Poor Worry Drug Makers.” by Gardiner Harris, The New York Times. NEW DELHI — Alka Kudesia needs an expensive drug to treat her breast cancer, but refuses to tell her children for fear they will take out loans to buy the medicine and spend the rest of . . . → Read More: The Cancer Divide: India’s Efforts to Aid Poor Worry Drug Makers
“San Antonio Breast Cancer Symposium Highlights.” by Dr. Robert Miller, #BCSM. The San Antonio Breast Cancer Symposium is the largest scientific meeting devoted to breast cancer, attracting national and international attention. It is attended by clinicians, researchers and advocates. “The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum . . . → Read More: San Antonio Breast Cancer Symposium Highlights by Dr. Robert Miller
“The Cancer Divide: Tackling a Racial Gap in Breast Cancer Survival.” by Tara Parker-Pope, The New York Times. The cancer divide between black women and white women in the United States is as entrenched as it is startling. In the 1980s, breast cancer survival rates for the two were nearly identical. But since 1991, as . . . → Read More: The Cancer Divide: Tackling a Racial Gap in Breast Cancer Survival
“GSK to stop paying doctors in major marketing overhaul.”By Ben Hirschler, Reuters. (Reuters) – GlaxoSmithKline will stop paying doctors for promoting its drugs and scrap prescription targets for its marketing staff – a first for an industry battling scandals over its sales practices, and a challenge for its peers to follow suit. Britain’s biggest drugmaker . . . → Read More: GSK to stop paying doctors in major marketing overhaul
“Annual Report to the Nation on the status of cancer.” Press Release, National Cancer Institute. The American Cancer Society, the Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Association of Central Cancer Registries collaborate annually to provide updates on cancer incidence and death rates and trends in these outcomes . . . → Read More: Annual Report to the Nation on the status of cancer
“San Antonio Breast Cancer Symposium Highlights.” by Dr. Julie Gralow, #BCSM. The San Antonio Breast Cancer Symposium is the largest scientific meeting devoted to breast cancer, attracting national and international attention. It is attended by clinicians, researchers and advocates. “The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum . . . → Read More: San Antonio Breast Cancer Symposium Highlights by Dr. Julie Gralow
“Reflections on FDA Warning to 23andMe.” by Jim Evans, The Cancer letter. There’s been much recent gnashing of teeth (at least within the narrow and rather insular world of do-it-yourself genomics) about the gall of the FDA in choosing to issue a warning letter to 23andMe, effectively shutting down marketing of their direct-to-consumer personal genomic . . . → Read More: Reflections on FDA Warning to 23andMe
“Cancer Survivors Celebrate Their Cancerversary.” by Bruce Feiler, The New York Times. The concept of the five-year survival rate for cancer was introduced in the 1930s. Initially, the designation was used for blood cancers, which grow fast and were extremely lethal at the time, said Dr. Siddhartha Mukherjee, a cancer specialist at Columbia University . . . → Read More: Cancer Survivors Celebrate Their Cancerversary
“Regulation Expert Weighs In on FDA Letter to 23andMe.” Mendelspod.com. On Monday, November 25th, the FDA sent a letter to the direct-to-consumer genetic testing company, 23andMe. The letter has received a bit more attention than the average FDA correspondence. The letter was addressed to 23andMe CEO, Anne Wojcicki, and told her that the company’s Personal . . . → Read More: Regulation Expert Weighs In on FDA Letter to 23andMe
“”Is it time to wash our hands of cause washing? Thoughts on Movember, Pinktober, Greenwashing, Catwashing?” By Nikki Reimer, Reimer Writes. There is a narrow line that all organizations must attend to when they enter the cause marketing realm. The Canadian Breast Cancer Foundation thinks that “the more public discussion about the issue, the greater . . . → Read More: “Is it time to wash our hands of cause washing? Thoughts on Movember, Pinktober, Greenwashing, Catwashing? |
||
| Copyright © 2025 Breast Cancer Consortium – Archives - All Rights Reserved. Privacy Policy | ||